Spinal Cord Stimulation (SCS) Clinical Data

Multiple Level 1 RCTs and real-world studies support the design of Boston Scientific’s SCS therapy. 

  

---

  

WaveWriter Alpha™ is the first SCS portfolio designed to deliver FAST™ — Fast-Acting Sub-perception Therapy, our proprietary therapy targeting a new and distinct mechanism of action in SCS called surround inhibition.⁸

Explore FAST Data

  

3x3 Clinical Evidence

  

Combination Therapy and Multiple Mechanisms

Boston Scientific advanced the science of spinal cord stimulation by introducing systems capable of engaging multiple mechanisms of action individually or simultaneously with Combination Therapy.

---

  

  

Sub-Perception Neural Dosing

Extensive neural dosing research led to the development of our optimized Contour™ Therapy which delivers broad paresthesia-free coverage across multiple neural targets — all while using a fraction of the energy of conventional high frequency stimulation.

  

Foundational Technology and Capabilities

Boston Scientific systems are equipped with foundational targeting technologies like the Illumina 3D Algorithm and Multiple Independent Current Control (MICC) which deliver excellent long-term pain relief, and the option to utilize multiple waveforms to increase patients’ chances of success with SCS.